NCT03758781 2023-04-14IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid TumorsH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed12 enrolled
NCT00210470 2020-12-11A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck CancerBrooklyn ImmunoTherapeutics, LLCPhase 2 Completed27 enrolled 16 charts